Clinical Trial Update: Prevention of Cardiovascular Disease With Polypill Among Pars Cohort Participants [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating a polypill for prevention of cardiovascular disease among Pars cohort participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Cardiovascular Diseases | Phase 3 | Status: UNKNOWN